Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1821 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Domain Therapeutics S.A.. (4/17/24). "Press Release: Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer". Strasbourg, Motnreal, QC & Boston, MA. 2024-04-17
MedinCell S.A.. (4/16/24). "Press Release: Medincell Enters into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies". Montpellier. 2024-04-16
Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes. 2024-04-15
HealthTech For Care. (4/3/24). "Press Release: HealthTech For Care Launches Its European Patient Observatory to Accelerate Healthcare Equality in Europe". Paris. 2024-04-03
Ipsen S.A.. (4/2/24). "Press Release: Ipsen and Sutro Biopharma Announce Exclusive Global Licensing Agreement for an ADC Targeting solid tumors". Paris & San Francisco, CA. 2024-04-02
Sparxell UK Ltd.. (4/2/24). "Press Release: Sparxell Raises $3.2m to Advance Development of Sustainable Pigments". Cambridge. 2024-04-02
SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris. 2024-03-27
Kranus Health GmbH. (3/25/24). "Press Release: Kranus Health Increases Funding to USD 20 Million Total, Cementing Its Position as a Leader in Virtual Care in Urology". Berlin, Munich & Paris. 2024-03-25
Tricares SAS. (3/25/24). "Press Release: Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer". Paris & Munich. 2024-03-25
Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology". 2024-03-21
Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. 2024-03-21
Mirador Therapeutics, Inc.. (3/21/24). "Press Release: Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases". San Diego, CA. 2024-03-21
Cure51 SAS. (3/20/24). "Press Release: Cure51 Raises a €15 Million Seed Round to Harness the Natural Power of Cancer Survivors to Develop First-in-Class Treatments and Transform Cancer into a Curable Disease". Paris. 2024-03-20
Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years". 2024-03-15
Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. 2024-03-14
Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. 2024-03-14
Pierre Fabre. (3/1/24). "Press Release: Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories". San Francisco, CA & Castres. 2024-03-01
Inpart SAS. (2/29/24). "Press Release: Inpart and Evaluate Announce Strategic Partnership to Optimize Biopharma Dealmaking". Lyon. 2024-02-29
Symrise AG. (2/29/24). "Press Release: Dr Jean-Yves Parisot Assumes CEO Position from Dr Heinz-Jürgen Bertram". Holzminden. 2024-02-29
Stilla Technologies SAS. (2/22/24). "Press Release: Stilla Technologies Closes $26.5M Series C Financing to Accelerate Commercialization of Its Digital PCR Platform – Expands Leadership team". Paris & Boston, MA. 2024-02-22
Biotimus SAS. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology". 2024-02-20
AZMed SAS. (2/20/24). "Press Release: AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI". Paris. 2024-02-20
StromaCare. (2/13/24). "Press Release: StromaCare Appoints Georges Rawadi as CEO". Lyon. 2024-02-13
Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier. 2024-02-09
GenSight Biologics S.A.. (2/8/24). "Press Release: GenSight Biologics Announces Completion of a €5 million capital Increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital". Paris. 2024-02-08
Theryq. (2/2/24). "Press Release: Theryq and Gustave Roussy Have Been Selected as Part of the "i-Démo" France 2030 Call for Projects". Rousset. 2024-02-02
Aqemia SAS. (1/30/24). "Press Release: Aqemia Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline". Paris. 2024-01-30
Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz". 2024-01-29
Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence. 2024-01-29
Pierre Fabre. (1/26/24). "Press Release: Eau Thermale Avène Hits a Billion Euros in Turnover, and Strengthens Its Medical Positioning". Toulouse. 2024-01-26
Sensorion S.A.. (1/19/24). "Press Release: Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries". Montpellier. 2024-01-19
Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. 2024-01-16
Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres. 2024-01-10
GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil. 2024-01-05
Sensorion S.A.. (1/5/24). "Press Release: Sensorion Announces Partnership with the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years". Montpellier. 2024-01-05
Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA. 2024-01-04
Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris. 2024-01-04
Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. 2024-01-03
PAI Partners SAS. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation". 2023-12-27
Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest eve 2023-12-26
GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris. 2023-12-22
UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". 2023-12-21
Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona. 2023-12-20
Owkin. (12/19/23). "Press Release: Owkin Enters Collaboration Agreement with MSD to Develop AI-powered Diagnostics for Cancer". 2023-12-19
HealthTech For Care. (12/18/23). "Press Release: HealthTech For Care Makes Governance Changes, Appointing Pierre Courteille as Chairman and Sophie Villedieu as Managing Director". Paris. 2023-12-18
Median Technologies S.A.. (12/14/23). "Press Release: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine". Sophia Antipolis & Saclay. 2023-12-14
Sofinnova Partners. (12/13/23). "Press Release: Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups". Paris. 2023-12-13
Sofinnova Partners. (12/13/23). "Press Release: Sofinnova Partners and Gustave Roussy Forge Strategic Alliance to Boost Oncology Startup Acceleration in France". Paris. 2023-12-13
Antabio SAS. (12/12/23). "Press Release: Antabio Raises €25 Million in Series B Financing". Labège. 2023-12-12
Sanofi S.A.. (12/11/23). "Press Release: Statement on FTC Challenge to Proposed License Agreement with Maze Therapeutics". Paris. 2023-12-11
Carthera SAS. (12/11/23). "Press Release: Carthera Brings Series B Round to €42M with Additional €4.5M Funding. Company Welcomes First US VC, Unorthodox Ventures". Paris. 2023-12-11
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". 2023-12-05
Aqemia SAS. (12/5/23). "Press Release: Aqemia Announces a Major Multi-year Collaboration of $140 Million with Sanofi". Paris. 2023-12-05
Sofinnova Partners. (12/5/23). "Press Release: Sofinnova Partners Unveils Sofinnova.AI – a Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment practice". Paris. 2023-12-05
Eligo Bioscience S.A.. (12/5/23). "Press Release: Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines". Paris. 2023-12-05
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". 2023-11-21
Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra". 2023-11-21
ECBF Management GmbH. (11/21/23). "Press Release: 17 Million Euros for Sustainable Agriculture. ECBF Leads RED Horticulture Series A Financing Round, Together with Demeter IM and Unigrains". Luxembourg. 2023-11-21
GenSight Biologics S.A.. (11/21/23). "Press Release: GenSight Biologics Announces a Successful Offering for an Amount of approximately €4.7 Million". Paris. 2023-11-21
GenSight Biologics S.A.. (11/20/23). "Press Release: GenSight Biologics Announces Launch of an Offering for an Indicative Amount of €5 Million that Has Received Subscription Commitments from New and Existing Shareholders Totaling €4 Million". Paris. 2023-11-20
Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. 2023-11-20
NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. 2023-11-15
T-Therapeutics Ltd.. (11/15/23). "Press Release: T-Therapeutics Raises £48 Million Series A for Development of Next Generation TCR Therapeutics to Transform Cancer Treatment". Cambridge. 2023-11-15
Nouscom AG. (11/14/23). "Press Release: Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round". Basel. 2023-11-14
Valneva S.E.. (11/10/23). "Press Release: Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. 2023-11-10
Valneva S.E.. (11/9/23). "Press Release: Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates". Saint Herblain. 2023-11-09
Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. 2023-11-07
LimFlow S.A.. (11/1/23). "Press Release: LimFlow Announces Agreement to Be Acquired by Inari Medical". Paris & San José, CA. 2023-11-01
MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. 2023-10-30
Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain. 2023-10-25
Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris. 2023-10-24
Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris. 2023-10-20
Global Bioenergies S.A.. (10/19/23). "Press Release: Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer". Evry. 2023-10-19
bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile. 2023-10-19
Mablink Bioscience SAS. (10/18/23). "Press Release: Mablink Bioscience Enters an Agreement to be Acquired by Lilly". Lyon. 2023-10-18
Owkin. (10/17/23). "Press Release: Servier Partners with Owkin with the Aim of Discovering and Developing AI-driven Precision Therapeutics". 2023-10-17
Panekès Partners SGR S.p.A.. (10/10/23). "Press Release: Panakès Partners Welcomes New Network and Portfolio Talent Advisor to Drive Growth and Innovation". Milan. 2023-10-10
LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. 2023-10-09
Global Bioenergies S.A.. (10/4/23). "Press Release: French Government Awards Global Bioenergies €16.4 Million to Help Fund Construction of the World’s First Biosourced Isobutene Plant". Évry. 2023-10-04
Orakl Oncology SAS. (10/4/23). "Press Release: Orakl Oncology Raises €3 Million to Develop Its Techbio Platform for Precision Oncology". Paris. 2023-10-04
EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. 2023-10-04
Exscientia plc. (10/3/23). "Press Release: Exscientia Details Pipeline Prioritisation Strategy". Oxford. 2023-10-03
Sanofi S.A.. (10/3/23). "Press Release: Sanofi Announces Agreement for Potential First-in-Class Vaccine against Extraintestinal Pathogenic E. coli". Paris. 2023-10-03
Kranus Health GmbH. (10/2/23). "Press Release: Kranus Health Now Raised a Total of USD 15 Million Series A Funding to Realize Its Vision of Integrated Care in Urology". Berlin, Munich & Paris. 2023-10-02
Abivax S.A.. (9/29/23). "Press Release: Abivax Files Registration Statement for Proposed Initial Public Offering in the United States". Paris. 2023-09-29
CellPhenomics GmbH. (9/29/23). "Press Release: Kyan Technologies, Alentis Therapeutics, and CellPhenomics Join Forces Combining Cutting-edge Optim.AI and PD3D Models to Advance Claudin-1 Expression Research". Singapore, Berlin & Allschwil. 2023-09-29
Cytel Inc.. (9/26/23). "Press Release: Cytel Continues Expansion of Market Access and Medical Communication Capabilities with the Acquisition of Co.faktor". Waltham, MA. 2023-09-26
CorWave S.A.. (9/26/23). "Press Release: CorWave Announces the Appointment of Magalie Durrèche as Chief Financial Officer". Clichy. 2023-09-26
Valneva S.E.. (9/25/23). "Press Release: Valneva Announces New Ixiaro Supply Contract with the U.S. Government Worth a Minimum of $32 Million". Saint Herblain. 2023-09-25
Argobio SAS. (9/25/23). "Press Release: Northern Gritstone and Argobio Studio Back Sheffield University Spin-out Crucible Therapeutics". Paris, Manchester & Sheffield. 2023-09-25
Traceless Materials GmbH. (9/25/23). "Press Release: Traceless Materials Secures €36.6 Million Series A to Build First Industry Plant for Bio-circular Alternative to Plastic". Hamburg. 2023-09-25
Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford. 2023-09-20
EverImmune. (9/19/23). "Press Release: EverImmune Secures €3.5 Million in Financing from Bpifrance". Villejuif. 2023-09-19
Thermosome GmbH. (9/19/23). "Press Release: Thermosome Establishes High-Profile Clinical Advisory Board". Munich. 2023-09-19
Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. 2023-09-18
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. 2023-09-18
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. 2023-09-12
Orbit Discovery Ltd.. (9/11/23). "Press Release: Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer". Texas & Oxford. 2023-09-11
iOmx Therapeutics AG. (9/5/23). "Press Release: iOmx Therapeutics Appoints Dr. Nils Peter Debus as Chief Business Officer". Martinsried. 2023-09-05
Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. 2023-08-23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page



Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top